Kidney Res Clin Pract.
2024 Jan;43(1):125-129. 10.23876/j.krcp.23.197.
Successful diagnosis and treatment of recurrent atypical hemolytic uremic syndrome posttransplantation caused by the heterozygous deletion of CFH in a patient with end-stage kidney disease of uncertain etiology
- Affiliations
-
- 1Division of Nephrology, Department of Internal Medicine, Presbyterian Medical Center, Jeonju, Republic of Korea
- 2Department of Laboratory Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
- 3Division of Nephrology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
- 4Transplantation Research Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
- 5Division of Nephrology, Department of Internal Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
- 6Department of Hospital Pathology, Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
- 7Department of Hospital Pathology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
- KMID: 2552849
- DOI: http://doi.org/10.23876/j.krcp.23.197
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Kidney Transplantation in Patients with Atypical Hemolytic Uremic Syndrome due to Complement Factor H Deficiency: Impact of Liver Transplantation
- Eculizumab therapy for recurrent atypical hemolytic uremic syndrome after kidney transplantation in atypical hemolytic uremic syndrome: a case report
- Recurrent hemolytic uremic syndrome caused by DGKE gene mutation: a case report
- Atypical hemolytic uremic syndrome and eculizumab therapy in children
- Plasma Exchange in the Treatment of Cyclosporine Induced Hemolytic Uremic Syndrome Following Kidney Transplantaion
